换一批
换一批FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition.
作者：
主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);细胞系, 肿瘤(Cell Line, Tumor);剂量效应关系, 药物(Dose-Response Relationship, Drug);抗药性, 肿瘤(Drug Resistance, Neoplasm);上皮-间质转化(Epithelial-Mesenchymal Transition);女(雌)性(Female);成纤维细胞生长因子2(Fibroblast Growth Factor 2);人类(Humans);小鼠, 裸(Mice, Nude);丝裂原活化蛋白激酶1(Mitogen-Activated Protein Kinase 1);丝裂原活化蛋白激酶3(Mitogen-Activated Protein Kinase 3);核蛋白质类(Nuclear Proteins);表型(Phenotype);喹唑啉类(Quinazolines);受体, 成纤维细胞生长因子, 1型(Receptor, Fibroblast Growth Factor, Type 1);信号传导(Signal Transduction);时间因素(Time Factors);转化生长因子β(Transforming Growth Factor beta);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.18632/oncotarget.13117
PMID
27825137
发布时间
2022-03-11
- 浏览8
Oncotarget
83424-83436页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
